These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10307029)
1. The other side of the fence: hospital P&T committee members' role in drug selection. Archambault GF Med Mark Media; 1978 May; 13(5):48, 50, 52 passim. PubMed ID: 10307029 [No Abstract] [Full Text] [Related]
2. Improving pharmacy and therapeutics committee operations. Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511 [TBL] [Abstract][Full Text] [Related]
3. When the pharmacy and therapeutics committee decides. Garrison TJ Hosp Pharm; 1979 Sep; 14(9):506-7. PubMed ID: 10243912 [No Abstract] [Full Text] [Related]
4. Developing an effective P & T Committee, Part 2. Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830 [TBL] [Abstract][Full Text] [Related]
5. Challenges of a P & T Committee in a community teaching hospital. Cooke DH; Kessler J Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706 [TBL] [Abstract][Full Text] [Related]
6. Hospitals defend formulary decisions against industry attacks. Talley CR Am J Hosp Pharm; 1978 Sep; 35(9):1154-5. PubMed ID: 696756 [No Abstract] [Full Text] [Related]
7. How to crack the $2 billion hospital market for pharmaceuticals. Zellmer WA Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527 [No Abstract] [Full Text] [Related]
8. P & T Committee formulary requests: criteria for admission. Weintraub M; Guttmacher L Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315 [TBL] [Abstract][Full Text] [Related]
9. A survey of selective administration procedures in formulary maintenance. Quigley MA; Brown WM Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001 [TBL] [Abstract][Full Text] [Related]
10. Formulary management to reduce cost: P & T committee strategies. Roberts MJ; Summerfield MR Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289 [TBL] [Abstract][Full Text] [Related]
11. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience. Lewis RP; Moore TD Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143 [TBL] [Abstract][Full Text] [Related]
12. P & T Committee role in advocating rational therapeutics. Borreson R Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625 [TBL] [Abstract][Full Text] [Related]
13. P&T Committee review of nifedipine GITS: new modality for angina and hypertension. Weintraub M; Horn J; Krakoff L; Vetrovec G Hosp Formul; 1990 Mar; 25 Suppl A():10-4. PubMed ID: 10103975 [TBL] [Abstract][Full Text] [Related]
15. Concerns of a pediatric hospital's P & T Committee: quality care emphasized over cost considerations. Reiley T; Wedemeyer H Hosp Formul; 1990 Oct; 25(10):1084-7, 1091. PubMed ID: 10107390 [TBL] [Abstract][Full Text] [Related]
16. The role of the Pharmacy and Therapeutics Committee in materiel management. Moss RL; Bowman JD; Smith W Hosp Mater Manage Q; 1990 Feb; 11(3):61-5. PubMed ID: 10103649 [No Abstract] [Full Text] [Related]
17. P & T committees and the hospital formulary. Evans PJ; Standish RC; Bell JE Hosp Formul; 1983 Sep; 18(9):892-5. PubMed ID: 10262367 [No Abstract] [Full Text] [Related]
18. Preparing the P & T committee agenda for new drug requests. Standish RC; Evans PJ; Bell JE Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929 [TBL] [Abstract][Full Text] [Related]
19. Formulary system controversies in the new environment of DRGs. Lipman AG Hosp Formul; 1985 Feb; 20(2):218, 221-4, 229 passim. PubMed ID: 10311021 [TBL] [Abstract][Full Text] [Related]
20. Drug-use evaluation of thrombolytic agents: a challenge to pharmacists. Green JA Am J Hosp Pharm; 1988 Oct; 45(10):2192-4. PubMed ID: 3228086 [No Abstract] [Full Text] [Related] [Next] [New Search]